TY  - JOUR 
AU  - Barbazán García, Jorge
AU  - Muinelo Romay , Laura
AU  - Vieito Villar, María
AU  - Candamio Folgar, Sonia
AU  - Díaz-López, A.
AU  - Cano, A.
AU  - Gómez-Tato, A.
AU  - Casares de Cal, M.e L
AU  - Abal, M.
AU  - López López, Rafael
PY  - 2014
SN  - 0020-7136
UR  - http://hdl.handle.net/20.500.11940/4499
AB  - Circulating tumor cells (CTCs), proposed as major players in cancer dissemination, have demonstrated clinical prognostic significance in several cancer types. However, their predictive value remains unclear. Here we evaluated the clinical utility of...
LA  - eng
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antibodies, Monoclonal, Humanized
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - Bevacizumab
KW  - Biomarkers, Tumors
KW  - Camptothecin
KW  - Capecitabine
KW  - Cetuximab
KW  - Colorectal Neoplasms
KW  - Deoxycytidine
KW  - Epithelial-Mesenchymal Transition
KW  - Female
KW  - Fluorouracil
KW  - Follow-Up Studies
KW  - Humans
KW  - Irinotecan
KW  - Liver Neoplasms
KW  - Male
KW  - Middle Aged
KW  - Neoplasm Staging
KW  - Neoplastic Cells, Circulating
KW  - Organoplatinum Compounds
KW  - Oxaliplatin
KW  - Prognosis
KW  - Survival Rate
TI  - A multimarker panel for circulating tumor cells detection predicts patient outcome and therapy response in metastatic colorectal cancer
DO  - 10.1002/ijc.28910
T2  - INTERNATIONAL JOURNAL OF CANCER
M2  - 2633
VL  - 135
ER  -